Navigation Links
Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006
Date:3/13/2008

found in note 1(b) to the December 31, 2007 audited consolidated financial statements. Amounts, unless specified otherwise, are expressed in U.S. dollars. Financial results are reported under U.S. generally accepted accounting principles. All per share amounts are stated on a diluted basis unless otherwise noted.

ANGIOTECH PHARMACEUTICALS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(in thousands of

U.S.$, except

per share data) December 31, 2007 December 31, 2006

As

Reported As Pre-

(Prelim- Adjust- viously Restate- As

inary) ments Revised Reported ments Restated

-------------------------------------------------------------------------

Statement of

------------

Operations

----------

License and

royalty fees 18,652 - 18,652 25,605 381 a. 25,986

Cost of

products

sold 95,529 (580) b. 94,949 68,067 1,476 b. 69,543

Selling,

general

and

administra-

tive 99,713 (398) c. 99,315 78,732 201 c. 78,933

Operating

(loss)

income (21,717) 978 (20,739) 60,222 (2,058) 58,164

Income (loss)

from

continuing

operations

before

income taxes

and

cumulative

effect of

change in

accounting (71,570) 978 (70,592) 22,173 (2,058) 20,115

Income tax

expense

(recovery) (23,608) 9,063 d. (14,545) 10,279 (8,187) d. 2,092

Net loss from

discontinued

operations,

net of taxes (11,395) 1,502 e. (9,893) (7,708) - (7,708)

Net (loss)

income for

<
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Angiotech and Rex Medical announce exclusive licensing and distribution agreement for the "Option(TM)" inferior vena cava filter
2. Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting
3. Angiotech announces results for the fourth quarter ended December 31, 2007
4. Angiotech to participate in Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
5. Angiotech Pharmaceuticals, Inc. - Notice of Conference Call and Webcast
6. Angiotech and Symphony Medical Announce Licensing Agreement
7. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
8. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech to participate in Bank of America 2007 Credit Conference
11. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... US-Australian drug discovery company, Novogen Limited (ASX: NRT; NASDAQ: ... progressing its ground-breaking technology platforms to Phase 1 clinical ... Company delivers the best value for shareholders. ... the Company currently had an extensive program of activities ... academic partnerships and initiatives, and he was working with ...
(Date:7/29/2015)... July 29, 2015  HealthSouth Corporation (NYSE: ... providers of post-acute healthcare services, offering both facility-based ... of operations for the second quarter ended June 30, ... characterized by strong volume growth in both segments ... said Jay Grinney, President and Chief Executive Officer ...
(Date:7/29/2015)... , July 29, 2015 ... has announced the addition of the "Global ... their offering. The Global Biosimilars Market, ... of the rapidly growing biosimilars market. With the ... striving to minimize costs, biosimilars are being viewed ...
(Date:7/29/2015)... YORK , July 29, 2015  Therapath ... testing, announces increased partnerships with VA and Military ... Epidermal Nerve Fiber Density (ENFD) and Sweat Gland ... small fiber neuropathy ( https://therapath.com/skin ). ... Nerve Fiber Density (ENFD) on punch skin biopsy ...
Breaking Biology Technology:Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10HealthSouth Reports Results for Second Quarter 2015 2HealthSouth Reports Results for Second Quarter 2015 3HealthSouth Reports Results for Second Quarter 2015 4HealthSouth Reports Results for Second Quarter 2015 5HealthSouth Reports Results for Second Quarter 2015 6HealthSouth Reports Results for Second Quarter 2015 7HealthSouth Reports Results for Second Quarter 2015 8HealthSouth Reports Results for Second Quarter 2015 9HealthSouth Reports Results for Second Quarter 2015 10HealthSouth Reports Results for Second Quarter 2015 11HealthSouth Reports Results for Second Quarter 2015 12HealthSouth Reports Results for Second Quarter 2015 13HealthSouth Reports Results for Second Quarter 2015 14HealthSouth Reports Results for Second Quarter 2015 15HealthSouth Reports Results for Second Quarter 2015 16HealthSouth Reports Results for Second Quarter 2015 17HealthSouth Reports Results for Second Quarter 2015 18HealthSouth Reports Results for Second Quarter 2015 19HealthSouth Reports Results for Second Quarter 2015 20HealthSouth Reports Results for Second Quarter 2015 21HealthSouth Reports Results for Second Quarter 2015 22HealthSouth Reports Results for Second Quarter 2015 23HealthSouth Reports Results for Second Quarter 2015 24HealthSouth Reports Results for Second Quarter 2015 25HealthSouth Reports Results for Second Quarter 2015 26HealthSouth Reports Results for Second Quarter 2015 27
... of the carbon nanotube, a team of researchers has ... that material. , Fixed between two electrodes, the vibrating ... radio--antenna, tunable filter, amplifier and demodulator--to tune in a ... back through an attached speaker. , Functional across a ...
... 1 Pharmasset, Inc.,(Nasdaq: VRUS ) ... first Chief,Development Officer, responsible for coordinating the ... programs. Dr. Rogers joins,Pharmasset from GlaxoSmithKline, where ... of Viral Diseases, responsible for antiviral discovery,activities ...
... SAN FRANCISCO, Calif., Nov. 1 Renovis,Inc. (Nasdaq: ... an overview of the company at the CIBC 18th ... November 7, 2007 at 11:30,a.m. Eastern Standard Time (8:30 ... the live audio broadcast and the subsequent archived audio,recording ...
Cached Biology Technology:World's smallest radio fits in the palm of the hand...of an ant 2World's smallest radio fits in the palm of the hand...of an ant 3Pharmasset Appoints Michael Rogers as Chief Development Officer 2Pharmasset Appoints Michael Rogers as Chief Development Officer 3
(Date:7/2/2015)... -- Fingerprint Cards has received an order for ... the distributor World Peace Industrial Group (WPI), part of WPG ... Asia . Deliveries are planned to take place during ... smartphone manufacturers in Asia . The order ... guidance of approximately 2,200 MSEK for 2015. Jörgen ...
(Date:6/30/2015)... , June 30, 2015 Genisphere ... as CEO to help further develop Genisphere,s therapeutics capabilities ... partnering experience, having spent much of the last 25 ... Amgen, Baxter Bioscience, and Johnson & Johnson. Tom started ... Technology and Biotech Corporate Finance. He graduated from Dartmouth ...
(Date:6/26/2015)... ATL Technology, LLC, a top provider of electromechanical ... use solutions, headquartered in Springville, Utah , ... California corporation with locations in Santa ... Rica ). This acquisition will incorporate MedConx,s ... ATL Technology,s existing facility in Costa Rica ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2
... left aside by big pharma and governments alike, are reasonably ... has to be paid to early diagnosis and correct treatment. ... need to be changed. So say scientists of the Antwerp ... research in Congo. The disease is caused by Mycobacterium ...
... examining 800,000-year-old polar ice, scientists increasingly are learning how the ... carbon dioxide has become more abundant in the Earth,s atmosphere. ... been examining ice cores collected from deep inside the polar ... interconnecting air spaces of old snow -- or firn air ...
... The decline of pollinator populations around the world and ... be the focus of the International Conference on Pollinator ... Penn State,s University Park campus. Conference sessions will cover ... leaf-cutting bees and bumblebees; worldwide pollinator status; the impacts ...
Cached Biology News:WHO guidelines on Buruli ulcer need adjustment 2Scientist links increase in greenhouse gases to changes in ocean currents 2
... traps a wide variety of solvent vapors that ... glass condensation flask (GCF400) allows for the collection ... easy draining. Rapid cooling time minimizes waiting period., ... quick solvent changes , -50?C ...
... Protein Phosphatase-2A (PPase-2A) is a serine/threonine phosphatase ... is isolated as the heterodimer of 60kDa ... the ability to dephosphorylate the a-subunit of ... PPase-2A has broad substrate specificity and may ...
... high performance spectral scanning multimode reader ... the advanced SkanIt Software it offers ... discovery assay development. Varioskan provides unlimited ... fluorescence and photometric assays and a ...
... of solvent vapors that can contaminate and degrade vacuum ... the collection of liquid into a self contained jar ... Ultra low -104 o C temperature ... Digital Display of temperature ...
Biology Products: